Career Background

• Focus on identifying opportunities in the Pharmaceutical sector
• years of Healthcare experience across the US, Europe, and India
• Previously CEO & Managing Director of Sequent Scientific, India’s largest animal health company and past investee company of Convergent
• Responsible for enhancing revenues at Sequent from ~$70 million to ~$180 million over a 6-year period
• Implemented an inorganic-led growth strategy at Sequent and Wockhardt

Work Experience

• 2022-present: Convergent Finance, Operating Partner – Pharmaceuticals
• 2022-present: Jagsonpal Pharmaceuticals, Managing Director
• 2014-2022: Sequent Scientific Limited, CEO & Managing Director
• 2010-2013: Strides Acrolab Limited, CEO - Pharma Business
• 1998-2009: Wockhardt Group, CEO of various divisions
• 1994-1998: Khandwala Securities, Senior Research Analyst
• 1993-1994: A F Ferguson & Co, Consultant

Education

• 1993: Masters in Management Studies, SP Jain Institute of Management and Research, Mumbai
• 1989: BE (Mechanical), Maharaja Sayajirao University, Baroda